Summary: Using online in vivo chemiluminescence (CL), we studied for the first time continuously the production of reactive oxygen species (ROS) after global cerebral ischemia and the relationship of ROS production to CBF. In anesthetized rats equipped with a closed cranial win dow, the CL enhancer, lucigenin (I mM), was superfused onto the brain topically. CL was measured through the cranial window with a cooled photomUltiplier, and CBF was measured simultaneously with laser-Doppler flow metry. Reperfusion after 10 min (n = 8) of global cerebral ischemia led to a CL peak to 188 ± 77% (baseline = 100%) within 10 ± 4 min. After 2 h of reperfusion, CL had returned to 102 ± 28%. Reperfusion after 20 min (n = 8) of ischemia increased CL to 225 ± 48% within 12 ± 3 min. After 2 h, CL was still increased (150 ± 44%, p < 0.05 compared with 10 min of ischemia). CL after 10 min of ischemia was neither affected by brain topical free CuZn superoxide dismutase (SOD) (100 U/ml, n = 3) nor by i.v. administration of free CuZn-SOD (104 U/kg, followed by
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There is increasing evidence that reactive oxygen species (ROS) are involved in hypoxic/ischemic tis sue damage in a number of organs, including the brain (for review see Halliwell et aI. , 1992; Trayst man et al. , 1991) . ROS formation as a potential mechanism of damage has to be considered primar ily when oxygen becomes available again after an ischemic episode (reperfusion after global isch emia), or when some oxygen tension within the tis sue is preserved to some degree (i. e. , in the isch emic penumbra around the focal ischemic core). Recently, interest in the involvement of ROS in ischemic damage to the brain has been renewed by the finding of a possible link between excessive ac tivation of glutamate receptors Cexcitotoxicity") and ROS-mediated tissue damage (Coyle and Putt farcken, 1993) .
Due to methodological difficulties in the in vivo detection of the extremely short-lived ROS, many issues regarding the role of ROS in ischemia remain unclear. In particular, the temporal pattern and the cellular sources of ROS production in ischemia/ reperfusion of the brain are unknown. As a conse quence, the relationship of ROS production to the complex pathophysiological sequelae of ischemia, such as changes in regional cerebral blood flow (rCBF) [i. e. , hyperperfusion or hypoperfusion (Dirnagl, 1993) ], postischemic leukocyte activation (Kochanek and Hallenbeck, 1992) , spreading de pression like ischemic depolarizations (Back et aI. , 1994) , etc. is unknown.
Methods currently available for monitoring ROS production in the brain in vivo lack temporal reso lution, and are therefore not well suited for studying the temporal dynamics of ROS production. In the process of chemiluminescence (CL), specific chem ical compounds (i. e. , luminol or lucigenin) react with ROS to produce light. CL is a well-established principle for monitoring ROS production in vitro (Kricka, 1993) with high sensitivity. Because light emission can be monitored continuously, CL in principle can be used for online measurement of ROS production. Archer (A rcher et aI. , 1989a) , Chance (Boveris et aI. , 1980) , and others (Paky et aI. , 1993) have pioneered the use of CL to study ROS production in isolated organs in vivo. It was the aim of this study to apply CL for the first time to study brain cortex surface ROS production in vivo in the reperfusion phase of global cerebral ischemia in the rat. Specifically, we addressed two questions, as follows .
• Does the duration of the ischemic interval influ ence the temporal pattern of ROS production?
• What is the temporal correlation of postischemic cerebral blood flow changes and ROS produc tion?
METHODS

General preparation
Male Wistar rats were anesthetized with thiobutabar biturate (Inactin, 100 mg/kg body weight, Byk Gulden, Konstanz, Germany), tracheotomized, and artificially A cooled photomultiplier (PMT) is focused via a reflector at brain tissue exposed by a closed cranial window. Chemiluminescence (Cl) is enhanced by brain topical infusion of lucigenin. The rat is anesthetized and venti lated, and arterial blood pressure and end expiratory Pco2 are monitored continuously and stored on a PC. Regional cerebral blood flow (rCBF) is measured with laser-Doppler flowmetry in the same area where Cl is re corded. Because the interference of the laser light with the PMT, rCBF is monitored dis continuously with a shutter closed in front of the PMT. The complete setup is housed in two dark boxes and a Faraday cage to pre vent electromagnetic radiation from the out side to interfere with Cl from the brain.
J Cereb Blood Flow Metab, Vol. 15, No. 6, 1995 ventilated (Harvard small-animal respirator, South Natick, MA, U.S.A.). All sites of surgical incisions were pretreated with the subcutaneous injection of lidocaine (1 %). The femoral artery and vein were cannulated for physiological monitoring and infusion of drugs. Via a mid line cervical incision, both common carotid arteries were isolated micro surgically from adhering tissue and nerves. Silastic loops (0.64 mm ID, 1.19 mm OD, Dow Corning Midland, MI, U.S.A.) were placed loosely around the vessels for later occlusion and release (see Induction of global cerebral ischemia, in a later section). The body temperature was measured and maintained at 38 ± 0.5°C. Arterial blood pressure and end-expiratory Pc02 (Heyer EGM I, Bad Ems, Germany) were monitored continu ously, blood gases were measured serially (Instrumenta tion Laboratory IL 1304, Milan, Italy), and the hemato crit was measured at the beginning and at the end of each experiment. Physiological variables including rCBF (see later herein) were analog/digital converted and processed and stored on a PC running the ASYST software (Mac Millan Software, New York, NY, U.S.A.). The animals were placed in a stereotactic frame, equipped with a closed cranial window over the right parietal cortex [dura removed, superfused with artificial cerebrospinal fluid (aCSF); for details see Dirnagl et aI., 1991b] , the lower part of the body of the animal (excluding the thorax) was housed in a plastic tube (inner diameter 7 em), which served as a negative pressure chamber for the induction of ischemia (see later herein). The animals were then po sitioned in ' a dark box for CL recording (Fig. 1) . All the surgical and experimental procedures were in accordance with institutional guidelines for animal experiments.
CBF measurement
Regional cerebral blood flow (rCBF) was measured con tinuously in the brain cortex with laser-Doppler flowme try (LDF). LDF quantitatively measures changes in mi crovascular rCBF over a wide range within a tissue vol ume of � 1 mm 3 (Dirnagl et aI., 1989) . We used a Vasamedics 403 A Blood Perfusion Monitor (Vasamed ics, St. Paul, MN, U.S.A.), connected to a needle probe (0.8-mm diameter). The LDF probe was positioned over the cortical area where CL was monitored. Due to the light sensitivity of the photomultiplier used for CL detec tion, no simultaneous recordings of rCBF and CL induced photon emission were made.
PMT-cooler Lucigenin super1usion
Respirator, I,v, Infusion Setup for in vivo CL recording CL was recorded using a cooled (-20°C) photomulti plier (Hamamatsu R943-02) with a dark count of 3 cps at -20°C. The counts of the photomultiplier were amplified and counted by a Hewlett-Packard Universal counter (HP 5316 B), connected to a PC for data recording and storage. To exclude photons from other sources than brain CL, the animal in the stereotactic frame was housed in a dark box and was covered with aluminum foil. Only the cranial window was left unshielded and was posi tioned under a reflector, reflecting the photons from the exposed brain onto the photon-sensitive area of the pho tocathode (Fig. I) . A shutter between the reflector and the photomultiplier enabled manipUlations of the animal with an open dark box. As an additional measure to pre vent photons and other electromagnetic waves unrelated to brain CL from the outside to contaminate the signal, the dark box with the animal and the detector was housed in a second, larger dark box, equipped with metal shield ing (Faraday cage). All the electrical equipment (respira tor, infusion pumps, end-expiratory CO2 monitor, etc. ) was positioned outside the cage. Because the unprotected laser-Doppler's glass fiber probe was guiding light from the outside into the dark box, it was specially shielded. LDF recordings were made only with the photomultiplier shutter closed. Phosphorescence, the delayed emission of photons resulting from the photon-induced electronic ex citation of specific atoms with lifetimes of the excited state of up to several hours, is a potential source of noise in the in vivo setup: A number of different, potentially phosphorescent materials are used in the construction of the cranial window. Therefore, all the materials used in side the dark box, including plastic tubes and the glass for the cranial window, were tested and selected for 0 or very low phosphorescence.
Lucigenin-enhanced CL
To record ROS production optically, topical superfu sion of the CL enhancer, lucigenin, was used. Lucigenin induced CL is particularly sensitive to superoxide (Paky et aI., 1993; Archer et aI. , 1989a; Caraceni et aI., 1994; Rembish and Trush, 1994) . Lucigenin (N,N'-dimethyl diacridinium, Sigma Chemicals), a fluorescent bivalent hydrophilic organic cation (Montano and Ingle, 1979; Tot ter et aI. , 1960) , is a standard CL probe for an array of in vitro (Kricka, 1993) and in vivo (Henry et aI., 1993; Arch er et aI. , 1989a Arch er et aI. , ,b, 1993 Henry et aI. , 1990; Montano and Ingle, 1979; Totter et aI. , 1960 ) ROS assays. Lucigenin, when univalently reduced to its corresponding radicals. reacts with ROS to produce dioxetane (Faulkner and Fri dovich, 1993) . The dioxetane then decomposes into two molecules of the acridone. one of which is electronically exicted and emits a photon in the blue-green spectral range. It is important to note that lucigenin itself does not produce CL with ROS. In the in vivo system, the reaction that reduces lucigenin to the CL-producing compound can therefore probably only take place intracellularly. Lucigenin is therefore particularly sensitive to the intra cellular production of ROS (Okuda et aI. , 1992; Peters et aI., 1990; Henry et aI. , 1989; Rembish and Trush, 1994) . Lucigenin dissolved in aCSF does not emit light at any partial pressure of oxygen (tested from 2 to 700 mm Hg; data not shown) in the absence of a radical generating system (i. e. , xanthin/xanthin oxidase). Even when super oxide is present, lucigenin-enhanced CL in vitro is not related to oxygen partial pressure over a wide range (Archer et aI. , 1989a) .
Induction of global cerebral ischemia
After recording of basal rCBF and brain CL photon count, the animal was removed from the dark box and both common carotid arteries w ere occluded by tighten ing the Silastic loops. Immediately afterward, rCBF was reduced to a level < 10% of resting flow for 10 min (groups I, III, and IV) or 20 min (group II) by applying negative pressure with a vacuum cleaner to the negative pressure chamber. When pressure around the body drops below the venous pressure, blood is pooled in the venous sys tem and systemic arterial pressure is lowered according to lower body negative pressure. The effects of lower body negative pressure do not differ from the conse quences of other types of acute hypotension (Wolthuis et aI. , 1974) . The circulatory effects of this simple model (Dirnagl et aI. , 1993) resemble the well established two vessel occlusion models combined with systemic hy potension (Smith et aI., 1984) ; however, bloodletting and reinfusion are avoided and no anticoagulation is neces sary. Hypotension and normotension and hence ischemia and reperfusion can be achieved as a step function and without trauma to blood cells.
Experimental paradigm (in vivo experiments)
The experimental protocol is summarized in Fig. 2 . Af ter implantation of the cranial window, the animals were immediately transferred to the dark box. After decline of phosphorescence of the brain and glass window (usually <30 min). superfusion of 1 mM lucigenin (1 mllh) in aCSF 
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was started. Because of the diffusion of lucigenin in the extracellular space and into the cells, -60 min were re quired to obtain a stable photon count. Then a CL base line was recorded for IS min, the cranial window was shielded with aluminum foil, and the animal was removed from the dark box for induction of ischemia. In group I (n = 8), ischemia was induced for 10 min; in group II (n = 8), ischemia was induced for 20 min. In two additional groups the effect of superoxide dismutase (CuZn-SOD, from bovine erythrocytes, Sigma Chemi cals) on CL was studied -group III (n = 3): Brain top ical superfusion of SOD (100 U/ml in aCSF, continuous superfusion started 30 min before induction of ischemia); group IV (n = 3): systemic administration of SOD [10,000 U/kg SOD in 1 ml of saline (0.9%) immediately before induction of ischemia, followed by the continuous infu sion of 10,000 U/kg/h SODJ. In groups III and IV, 10 min of global cerebral ischemia were applied. In control ani mals (group V, n = S) the common carotid arteries were manipulated but not occluded. In all groups, before and during occlusion, rCBF was continuously recorded with LDF. After induction of reperfusion by reopening the ca rotid arteries and releasing lower negative pressure, the animals were returned immediately to the original posi tion in the dark box as quickly as possible. This proce dure took a maximum of S min. CL was recorded contin uously for the next 2 h. rCBF was recorded intermittently every S min within the first 30 min of reperfusion and then every 30 min until the end of the experiment.
Cell culture experiments
To demonstrate that CN S cells are capable of taking up lucigenin intracellulariy, we loaded astrocytes, cerebral endothelial cells, and cerebellar granule cells (all from rat, standard preparation after Raizada et al., 1987; Marin et aI., 1993; Andreeva et aI., 1991, respectively) for 30 min with 10-5 M lucigenin. After washing the cells, the intra cellular localization of lucigenin was examined by fluo rescence microscopy (excitation 360 nm, emission SOO nm).
Brain slice experiments
To exclude a direct influence on CL measurements of the dramatic changes in CBF during and after ischemia, and to further examine the source of the signal, we stud ied CL during and after hypoxia in brain slices. In con trast to the in vivo preparation, monitoring of CL during hypoxia was feasible in these experiments. Because the chamber with the brain slice remains in the same position under the photomultiplier throughout the whole experi ment, artifacts can be minimized. In addition, access to the extracellular space of topically applied large mole cules (like SOD) or carriers (like liposomes) into the brain tissue is facilitated in the brain slice. In vivo, the pia arachnoid complex and the glia limitans may present a barrier to the diffusion of these substances into deeper layers of the cortex in the cranial window preparation.
Brain slices (SOO /Lm thick, containing parietal neocor tical and hippocampal tissue) were prepared in standard technique (Dingledyne, 1984) from male Wi star rats (200-300 g) and transferred to a warmed chamber (37°C). In the chamber (capacity one slice), the brain slices were super fused with aCSF (bubbled with 9S% O2 and S% CO2, warmed to 37°C; for composition see Them, 1993) . The O2 tension and temperature inside the chamber were J Cereb Blood Flow Metab, Vol. 15, No. 6. 1995 monitored with a Licox P02 monitor (GMS Medizinische Sondentechnik, Kiel-Mielkendorf, Germany). The cham ber was positioned under the photomultiplier and the dark box was closed. Because of the better access to the ex tracellular space in the brain slice, lower concentrations of lucigenin compared with the in vivo experiments pro duced the same signal/noise ratio. The brain slices were therefore incubated with 10-4 M lucigenin. After obtain ing a stable CL baseline (-30 min after the start of luci genin loading and 60 min after the slice procedure), the oxygenated aCSF (Poz inside the brain slice chamber >S30 mm Hg) was switched to hypoxic aCSF bubbled with 95% Nz and S% CO2 (P02 < 8 mm Hg) containing 10-4 M lucigenin. The POz inside the brain slice chamber dropped below 10 mm Hg within 2-3 min. After IS min of hypoxia, the aCSF was switched back to the oxygenated aCSF. The P02 inside the brain slice chamber returned above SOO mm Hg within 2-3 min. The temperature inside the brain slice chamber was not atTected by these manip ulations.
We studied three groups (Fig. 2) . Group I (n = S slices from 4 animals): no addition of antioxidants to the aCSF (control). Group II (n = 4 from 4 animals): addition of 100 U/ml SOD to the aCSF. Group III (n = 4 from 4 animals): addition of 5% liposome entrapped SOD.
Liposome-encapsulated SOD was prepared according to Szoka and Papahadjopoulos (Szoka and Papahadjo pOUlos, 1978) . Briefly, 198.9 mg dipalmitoyl L-a phos phatidylcholine (Sygena;' Switzerland), 4S.6 mg choles terol (Merck, Germany), and 19.2 mg stearylamine (Sigma Chemicals) were dissolved in 23 ml of diisopro pylether and 4S ml trichloromethane. The lipid solution was mixed with IS ml CuZn-SOD (Sigma Chemicals, from bovine blood, IS0,000 U) solution in HEPES buffer (4 mM, pH 7.4). The lipid/enzyme/buffer solution was sonicated using a Branson Sonlfier 2S0 (Branson Ultra sonics, U.S.A.) for 1 min and an emulsion was formed. The organic solvent system was removed by rotary evap oration at 4SoC on two vacuo stages. After liposome prep aration the unencapsulated SOD was separated from the vesicles by centrifugation three times with 60 ml of HEPES butTer (pH 7.4) at IS,OOO g for 30 min. The lipo some pellet was resuspended in buffer. Liposomes con tained 43 U SOD/ml liposomal solution as determined by Ransom test (Randox, Ireland) . The size of the liposomes was measured by light scattering (Coulter model N4) and showed means of 213 nm (3 1%) and 866 nm (69%). Be cause of the large size of the liposomes and the restricted access to the extracellular space in the in vivo cranial window preparation (see previous description), liposome entrapped SOD was only used in the brain slice experi ments.
Statistical analysis
All data are reported as means ± standard deviation (SD). Differences in CL, rCBF, and physiological vari ables between groups were analyzed using analysis of variance.
RESULTS
Physiological variables
The physiological variables are summarized in Table 1 . Except for the induced hypotension and a short period of hypercapnia and acidosis during global ischemia (data not shown), all the physiolog ical variables were within physiological limits throughout the experiment. Physiological variables were not statistically significantly different between the experimental groups.
Brain CL in vivo
Unenhanced CL After decay of brain phospho rescence (�50 cps) due to the intense lighting of the brain during surgery and before the superfusion of lucigenin, photon counts above baseline were re corded. This unenhanced photon count (�6 cps) de creased with the death of the animal (data from pilot series, not shown), but was not sensitive to short periods of induced hypoxia or hyperoxia of the an im al. This photon count presumably represents spontaneous, ultraweak CL possibly related to the (Boveris et al. , 1980) . Because the chemical source of un enhanced, ultraweak CL at this wavelength range is still con troversial (Kanofsky, 1988) and because this signal was only two times above the noise level, unen hanced CL was not used for monitoring of oxidative metabolism and ROS production in our experi ments. The unenhanced CL photon count from rat brain in our study correlates well with measure ments from dog brain where 30 cps/cm 2 were counted (B. Chance, unpublished observations). Due to the small size of the rat brain and hence cranial window size (�0. 25 cm 2 ), the rat is probably not suited in principle for unenhanced brain CL measurements.
Enhanced CL (baseline). Infusion of lucigenin led to a rise in the lucigenin-enhanced photon count to 32 ± 9 cps (groups I and II pooled). This count was sensitive to hyperoxia (inhalation of 100% oxygen, Fig. 3A ) and hypoxia (inhalation of 100% nitrogen, Fig. 3B , data from pilot series). The i. v. injection of KCI and subsequent death of the animal led to a decrease in the lucigenin-enhanced photon count, which reached dark count within minutes (Fig. 3C) . Enhanced CL (ischemia and reperfusion). Be cause the animals had to be removed from the dark box for the induction of ischemia, no CL was re corded during the ischemic interval. After 10 min of global ischemia (group 1), CL peaked within 10 ± 4 min after reperfusion onset to a photon count 188 ± 77% of baseline. Twenty minutes of ischemia (group II) led to a CL peak 225 ± 48% of baseline within 12 ± 3 min after reperfusion onset (Table 2 and Fig. 4) . Two hours after reperfusion onset, CL had returned to baseline 002 ± 28%) in group I, whereas CL was still increased in group II (150 ± 44%, p < 0.05 compared with group I). In control animals (n = 5) CL remained stable over the obser vation period.
Relationship of CL and rCBF. rCBF in both groups showed the typical pattern for global cere bral ischemia and reperfusion (T able 2): Occlusion of both common carotid arteries combined with hy pobaric hypotension led to severe ischemia (rCBF < 15% of baseline). On reperfusion, hyperperfusion developed (group I, 170 ± 45%; group II, 195 ± 53%), followed by hypoperfusion (rCBF at 2 h of reperfusion: group I, 77 ± 28%; group II, 68 ± 31%). The hyperperfusion peak in rCBF always preceded the CL peak, which is reflected in the shorter onset of reperfusion to peak times for rCBF compared with CL (Table 2) . A typical example for this rCBF-CL pattern is shown in Fig. 5 .
Effect of SOD. Neither brain topical (group III) nor i. v. (group IV) application of SOD affected reperfusion CL or rCBF (Table 2) . Baseline (Bl) Cl before induction of ischemia, corrected for the dark count of the detector, was defined as 100%. P < 0.05 denotes statistically significant difference between both groups (analysis of variance).
In vitro experiments
Cell culture. Cultured astrocytes, brain microvas cular endothelial cells, and neurons showed homo geneous fluorescence at 36 0 nm excitation wave length after incubation (30 min) with lucigenin (10-5 M).
Brain slice. Analogous to our in vivo findings, brain slices showed baseline CL, which was en hanced by the superfusion of 10-4 M lucigenin.
Switching the normoxic aCSF (Po2 > 500 mm Hg) to hypoxic aCSF (Po2 < 10 mm Hg) for 15 min led to a characteristic CL pattern (a typical example is shown in Fig. 6 ) very similar to the one observed in vivo with global cerebral ischemia (Fig. 5) : A very TABLE 2. Chemiluminescence (CL) and regional cerehral hlood flow (rCBF) data: group I (10 min of glohal ischemia), n = 8; group II (20 min of glohal ischemia), n = 8; group /11 [10 min of glohal ischemia and hrain topical superoxide dismutase (SOD)], n = 3; group IV (10 min of glohal ischemia and i.v. SOD), n = 3. CL data are corrected for the dark count of the detector Hatched area: Ischemia. Note that the peak in rCBF after onset of reperfusion precedes the peak in Cl by several minutes. Cl is still above baseline after 60 min of reperfusion, while rCBF already shows hypoperfu sian. To induce ischemia, the animal had to be removed from the dark box. The low count rate during the 20-min ischemic interval therefore reflects the dark count of the photomulti plier due to the closed shutter. For rCBF measurements dur ing the postischemic period, the shutter had to be closed. During these measurement intervals Cl is not recorded and the count drops to the dark count.
rapid decrease in CL during hypoxia, which ap proximated darkcount levels, was followed imme diately after reoxygenation by a rise in CL to levels approximately three to fourfold of baseline CL (data summary is given in Fig. 7) . After 60 min, CL had returned to baseline. Addition of 100 U/ml SOD to the aCSF did not change this pattern either qual itatively or quantitatively (Fig. 7) . However, addi tion of liposome-entrapped SOD decreased the reoxygenation CL peak significantly (Fig. 7) .
DISCUSSION
In this study we have demonstrated that lucige nin-enhanced CL can be used to study continuously the temporal pattern of ROS production from the surface of the brain cortex in the early reperfusion phase after global cerebral ischemia in anesthetized rats. We found that after reperfusion there is a CL burst, and that CL returns to baseline within 60 min after a relatively short ischemic interval (10 min) or remains elevated after a longer ischemic interval (20 min). The reperfusion-induced peak of rCBF al ways preceded the peak in CL. Free SOD, given either topically or i. v. to the brain, did not affect postischemic CL. In addition, we showed that hyp oxia and reoxygenation cause a very similar CL pat- tern in lucigenin-Ioaded brain slices. The reoxygen ation-induced CL burst in brain slices was affected by liposome-entrapped SOD but not by free SOD.
The following discussion will evaluate enhanced CL as a potential tool to study brain ROS produc tion, followed by an assessment of our data with particular emphasis on the relationship of our find ings to other studies concerning the role of ROS in cerebral ischemia.
Enhanced CL to study ROS production from the brain surface
Enhanced CL is a standard analytical technique to study ROS production in vitro and in isolated cell systems [i. e., monitoring of ROS production of ac tivated leukocytes (Samuni et ai. , 1991) ]. It has been used to measure ROS production in cell-free systems (Pascual and Romay, 1992) , single cells (Suematsu et ai. , 1989) , cultured cells (Caraceni et ai. , 1994; Rembish and Trush, 1994) , bacteria (Pe ters et ai. , 1990), homogenized organs (Imaizumi et ai. , 1984) , and ex vivo perfused organs (Omar et ai. , 1991; Okuda et ai. , 1991 Okuda et ai. , , 1992 Paky et ai. , 1993; Archer et ai. , 1989a; Henry et ai., 1990; Archer et ai. , 1993; Ikai et ai. , 1994) . The main advantage of enhanced CL, compared with other ROS measure ment techniques, is its high sensitivity, high tempo ral resolution, and noninvasiveness. The two most widely used CL enhancers are luminol and lucige nino It is widely accepted that luminol mainly reacts with hydrogen peroxide, whereas lucigenin is pri marily sensitive to superoxide (Paky et ai. , 1993; Archer et ai. , 1989a; Caraceni et ai. , 1994) . Lucige nin was used in this study because of its relative sensitivity to superoxide, and the fact that luminol may not be suited as an enhancer for extended mea surement periods (Samuni et ai. , 1991) . When used to study intact organ ROS production in vivo, sev eral methodological issues of lucigenin-enhanced CL have to be considered, including the source of signal and sample volume, the relationship of en hanced CL to CBF changes, potential toxicity or side effects of the enhancer, and the pH depen dence of CL. We will discuss these issues in the following paragraphs.
Source of the CL signal. Lucigenin has to be uni valently reduced to produce ROS-induced CL (Faulkner and Fridovich, 1993) . Lucigenin can be reduced in vitro by enzymes such as xanthine oxi dase. This accounts for the fact that lucigenin acts as a potent CL enhancer in superoxide-generating systems in vitro (i. e. , xanthine/xanthine oxidase). CL in those systems can be almost completely abol ished by treatment with SOD, but not by catalase, demonstrating the specifity of lucigenin-enhanced CL to superoxide (Archer et ai. , 1989a) . In intact cells or tissue, however, there is no extracellular reduction of lucigenin. Instead, lucigenin is taken up by the cells and reduced intracellularly. This ex plains why treatment with SOD, which does not penetrate into intact cells, may not or may only J Cereb Blood Flow Melab. Vol. 15. No. 6. 1995 partially attenuate CL in these systems (Peters et ai. , 1990; Okuda et ai. , 1992) .
In our in vivo experiments, brain topical or i. V. application of free SOD neither affected the preis chemic baseline CL nor the pattern or amplitUde of the CL response to 10 min of global cerebral isch emia in those animals. Because free SOD is re stricted to the extracellular space, and the access of the relatively large SOD molecule (MW 32, 500) is hindered by the pia-arachnoid complex and the glia limitans, we conducted brain slice experiments. Hypoxia/reoxygenation-induced CL in brain slices closely resembled the one observed in vivo (com pare Figs. 5 and 6). As in the in vivo brain, free SOD did not affect reoxygenation CL. However, lipo some-entrapped SOD, which is capable of entering into cells (Yusa et ai. , 1984) , strongly attenuated the hyperoxygenation CL burst (Fig. 7) . Together with the fact that we found lucigenin fluorescence intra cellularly in cultured brain cells, we conclude that the CL we observed mainly derived from intracel lular superoxide production.
Because CL-enhancing systems are available for the detection of a number of radical species with very high sensitivity [i. e. , nitric oxide, sensitivity in the fern to-to attomolar range (Kikuchi et ai. , 1993) ], we believe that the method proposed here can be modified to study free radicals other than superoxide.
Sample volume. The CL emission of lucigenin is in the blue/green spectral range. The penetration depth of light in brain at which optical power is reduced to 37% is �500 fLm (Eggert and Blazek, 1987) at a wavelength of �500 nm. In the rat parietal neocortex with removed dura, the CL signal there fore derives from the brain surface and from the outer layers of the cortex.
Relationship of blood flow changes to enhanced CL. Because the pattern of the initial peak of CL after reperfusion onset closely resembles the rCBF hyperperfusion pattern (Fig. 5 and Dirnagl et ai. , 1993) , the question arises whether the dramatic rise in blood flow may have affected lucigenin-enhanced CL. Potential mechanisms for such an effect in clude spontaneous CL of blood components such as leukocytes or mechanical factors such as blood volume-dependent changes of optical properties of the brain tissue (optical transmission, changes of surface angles, etc. ).
In our experiments we have collected several in dependent lines of evidence that CL is not directly affected by changes in blood flow, as detailed in the following.
Short periods of hypoxia (inhalation of 100% N2)
produce an immediate decrease in CL, although rCBF rises dramatically during hypoxia (Fig. 3B , rCBF measured but not shown in the graph). Hy peroxia, which increases the rate at which ROS are produced in the normal brain (Freemann and Crapo, 1981; Yusa et al. , 1987) , induces an in crease in CL (Fig. 3A) , although CBF is not af fected. Induction of 15 min of hypoxia followed by reox ygenation in brain slices produces a very similar pattern of CL, including a reoxygenation peak, as in the in vivo ischemia experiments (compare Figs. 5 and 6), but in the absence of hyperemia. It is interesting to note that Schiff and Somjen (1985) have observed a very similar pattern in brain slice P0 2 after reoxygenation. The hyperperfusion peak in rCBF always pre ceded the reperfusion peak in CL by several min utes.
Potential toxicity or side effects of the enhancer. The effects of lucigenin on the brain are purely de fined. Superfusion of the brain with lucigenin (1 mM in aCSF) has no known effects on CBF and metab olism. In a pilot series, we found no effect of luci genin on rCBF measured with LDF, nor did it affect the intactness of the blood-brain barrier as assessed with confocal laser scanning microscopy in vivo (Dirnagl et al. , 199Ib) . The postischemic rCBF changes are well charac�e rized in ' our model and were not changed by top ical superfusion of lucigenin to the brain. In addi tion, the viability of CNS cells in culture was not affected by the addition of 10 -5 M lucigenin to the medium. We are therefore confident that lucigenin did not affect brain function or rCBF in a significant way.
pH dependence of CL. Lucigenin-enhanced CL is pH sensitive (Montano and Ingle, 1979) . Because profound changes in intracellular pH occur during and after ischemia, the question arises whether CL measurements are valid under these conditions. The quantum yield of lucigenin-enhanced CL rises with increasing pH, with an optimum around pH 10. During ischemia and in the early reperfusion phase after global cerebral ischemia, brain intracellular pH becomes acidic (Tomlinson et al. , 1993) . Be cause we found an increase in CL during a phase of intracellular acidosis, the pH sensitivity of lucige nin-enhanced CL may have blunted the response. A decrease in pH of -0. 5 U, which might be expected in our experimental paradigm (Dirnagl et aI. , 1991a) , decreases CL only slightly. Because no quantitation of ROS production was attempted in our study, a confounding effect of changes in intracellular pH during the observation period IS un likely.
Comparison to other studies and implications for the role of ROS in ischemia and reperfusion Experimental strategies to study the role of ROS. Although there is mounting indirect evidence that ROS play an important role in ischemic damage, direct proof is hampered by the extremely high re activity of ROS and therefore the short biological half-life of ROS.
Indirect strategies to study the role of ROS for ischemic damage have used compounds that inter act with ROS production (particularly ROS scaven gers; for overview see Traystman et al. , 1991) , and more recently transgenic approaches were used [i. e. , Cu-Zn-SOD overexpressing mice (Kinouchi et al. , 1991; Halliwell et al. , 1992) ]. With very few exceptions, these studies have shown in a number of different ischemia models and species that exper imentally induced increases in the capacity of the brain to cope with oxidative stress are neuroprotec tive.
A number of techniques have been developed to study more directly the production and mechanisms of ROS in brain ischemia. These include the mea surement of relatively stable oxidation products of ROS [i. e. , electron spin resonance spectroscopy (Sen and Phillis, 1993) , nitroblue tetrazolium reduc tion , DAB-Mn 2+ -cytochemistry ], or measurement of the induc tion or depletion of endogenous ROS scavengers. Each of those methods presents specific advantages over others: high spatial resolution (DAB-Mn 2+ cytochemistry), high specificity (electron spin res onance spectroscopy), high sensitivity (CL), and so on. Taken together, studies attempting to measure ROS production after cerebral ischemia and reper fusion, including the present study, also support the hypothesis that ROS are produced in significant amounts under ischemic conditions and may there fore participate in ischemic damage.
Temporal pattern and cellular source ofpostisch emic ROS production. The current study is the first to attempt continuous measurement of brain ROS production during reperfusion after global cerebral ischemia. Discontinuous measurements using the nitroblue tetrazolium reduction technique , electron spin resonance spectroscopy (Sen and Phillis, 1993) , and salicylate-trapping mi crodialysis (Zhang and Piantadosi, 1994) are com patible with the findings of our study that there is a very early peak in ROS production on reperfusion, that the amount and temporal pattern of ROS pro duction is dependent on the duration of the isch-emic interval, and that after prolonged global cere bral ischemia ROS production can be sustained for hours (Sen and Phillis, 1993) . Similar findings have been reported in ischemia/reperfusion of the heart (Henry et aI. , 1993) and point to continuing accu mulation of substrate during ischemia for ROS pro duction on reoxygenation.
It is important to note that each of the various methods applied to measure ROS production sam ples different, rather ill-defined compartments. It is likely that the nitroblue tetrazolium reduction tech nique as well as the superfusion of spin traps for electron spin resonance spectroscopy or chemical traps in microdialysis studies sample ROS produced in the extracellular space. CL after topical superfu sion of lucigenin probably reflects mainly the intra cellular generation of ROS (see previous discus sion). The combined evidence from these studies and our study then suggests that on reperfusion ROS appear in the extracellular as well in the intra cellular space. In an elegant study, Kontos et ai. (1992) describe a technique to study superoxide production with electron microscopic resolution (DAB-Mn 2+ -cytochemistry). They report that in the reperfusion phase after global cerebral ischemia in the cat, superoxide can be detected in the extra cellular space associated with blood vessels and oc casionally in smooth muscle and endothelial cells. Based on previous findings of their group, they speculate that the superoxide was produced intra cellularly and exited the cells via the anion channel (Kontos et aI. , 1985) . Interestingly, they did not find superoxide production in the brain parenchyma. In the cat, the pia-arachnoid and the membrana glia limitans present a much greater barrier for the in traparenchymal penetration of topically applied substances than in rats. It is therefore unclear whether this negative finding was caused by the lack of penetration of their ROS indicator. From our present study it cannot be concluded whether CL was recorded from the meninges and pial circu lation (smooth-muscle cells and endothelium) only or from the brain parenchyma as well. Because top ically superfused lucigenin penetrates well into the parenchyma in rats, and because brain slices (with out meninges or blood circulation) also responded with a CL peak to hypoxia/reoxygenation (Fig. 3C) , we speculate that parenchymal cells were involved in ROS production in our series as well.
In our study we have demonstrated that postisch emic hyperperfusion and lucigenin-induced CL do not coincide: The peak in rCBF always preceded the peak in CL by several minutes. It is likely that this delay reflects the diffusion of oxygen from the blood to the ischemic cells and the time needed for the induction of several intracellular systems (mito chondria, xanthine oxidase, prostaglandin biosyn thesis, etc. ) to produce ROS. This does not pre clude the possibility that blood components, partic ularly polymorphonuclear leukocytes (PMLs), also produced ROS during the early reperfusion period. However, PMLs are an unlikely source for ROS production in the early phase of reoxygenation. In the same ischemia model we were unable to dem onstrate early leukocyte activation in the outer lay ers of the brain cortex using confocal laser scanning microscopy in vivo (Dirnagl et aI. , 1994) .
Methodological an d pathophysiological implica tions. Enhanced CL is a promising tool for studying the kinetics of ROS production from brain tissue with high temporal resolution and sensitivity. By using other CL-enhancing systems than lucigenin, a number of radical species, including NO (Kikuchi et aI. , 1993) , may be investigated. Our findings con tribute to the hypothesis that reperfusion-induced ROS production is burst-like and occurs very early upon reperfusion. If this is correct and ROS pro duction indeed triggers a cascade of cell damage, therapy aiming at the direct prevention of ROS mediated' damage (particularly ROS scavengers) should be administered very early. Depending on the duration and severity of the ischemic period, there may be a sustained production of ROS, which argues for an additional beneficial effect of post treatment with ROS scavengers.
